CedrusinCAS# 75775-36-9 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 75775-36-9 | SDF | Download SDF |
PubChem ID | 11210164 | Appearance | Powder |
Formula | C19H22O6 | M.Wt | 346.4 |
Type of Compound | Lignans | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2S,3R)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-5-(3-hydroxypropyl)-2,3-dihydro-1-benzofuran-7-ol | ||
SMILES | COC1=C(C=CC(=C1)C2C(C3=CC(=CC(=C3O2)O)CCCO)CO)O | ||
Standard InChIKey | PKORXOLYTWDULG-KBXCAEBGSA-N | ||
Standard InChI | InChI=1S/C19H22O6/c1-24-17-9-12(4-5-15(17)22)18-14(10-21)13-7-11(3-2-6-20)8-16(23)19(13)25-18/h4-5,7-9,14,18,20-23H,2-3,6,10H2,1H3/t14-,18+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Cedrusin shows a cytotoxic effect on A375 and HeLa cells. |
Targets | Caspase | PARP |
Cedrusin Dilution Calculator
Cedrusin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.8868 mL | 14.4342 mL | 28.8684 mL | 57.7367 mL | 72.1709 mL |
5 mM | 0.5774 mL | 2.8868 mL | 5.7737 mL | 11.5473 mL | 14.4342 mL |
10 mM | 0.2887 mL | 1.4434 mL | 2.8868 mL | 5.7737 mL | 7.2171 mL |
50 mM | 0.0577 mL | 0.2887 mL | 0.5774 mL | 1.1547 mL | 1.4434 mL |
100 mM | 0.0289 mL | 0.1443 mL | 0.2887 mL | 0.5774 mL | 0.7217 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 17-AAG (KOS953)
Catalog No.:BCC2121
CAS No.:75747-14-7
- Eupalinilide D
Catalog No.:BCN2523
CAS No.:757202-14-5
- Eupalinilide C
Catalog No.:BCN2522
CAS No.:757202-11-2
- Eupalinilide B
Catalog No.:BCN2521
CAS No.:757202-08-7
- Leflunomide
Catalog No.:BCC1256
CAS No.:75706-12-6
- 5-Amino-2-methylindole
Catalog No.:BCC8731
CAS No.:7570-49-2
- Isradipine (Dynacirc)
Catalog No.:BCC3797
CAS No.:75695-93-1
- 2,4-Dihydroxy-4,6-dimethoxydihydrochalcone
Catalog No.:BCN1363
CAS No.:75679-58-2
- 4-Acetyl-1,1-dimethylpiperazinium iodide
Catalog No.:BCC6616
CAS No.:75667-84-4
- Strobamine
Catalog No.:BCN1943
CAS No.:75656-91-6
- Boc-D-Asn-OH
Catalog No.:BCC3362
CAS No.:75647-01-7
- DSLET
Catalog No.:BCC5718
CAS No.:75644-90-5
- 3-Acetoxyflavone
Catalog No.:BCC9200
CAS No.:7578-68-9
- ADX 10059 hydrochloride
Catalog No.:BCC6171
CAS No.:757949-98-7
- Prosapogenin CP4
Catalog No.:BCN2534
CAS No.:75799-18-7
- Momordicoside A
Catalog No.:BCC8340
CAS No.:75801-95-5
- Dehydroevodiamine Chloride
Catalog No.:BCN6651
CAS No.:75853-60-0
- Rimcazole dihydrochloride
Catalog No.:BCC7090
CAS No.:75859-03-9
- 1-(3,5-Di-tert-butyl-4-hydroxyphenyl)-2-(2-(3-hydroxypropylamino)-5,6-dimethyl-1H-benzo[d]imidazol-1-yl)ethanone
Catalog No.:BCC1481
CAS No.:758679-97-9
- Bay 65-1942 R form
Catalog No.:BCC1410
CAS No.:758683-21-5
- [Nle4,D-Phe7]-α-MSH
Catalog No.:BCC5963
CAS No.:75921-69-6
- 11-Hydroxycanthin-6-one
Catalog No.:BCN3104
CAS No.:75969-83-4
- Pancreatic Polypeptide (human)
Catalog No.:BCC5711
CAS No.:75976-10-2
- Camphor
Catalog No.:BCN8297
CAS No.:76-22-2
Hazelnut (Corylus avellana L.) Shells Extract: Phenolic Composition, Antioxidant Effect and Cytotoxic Activity on Human Cancer Cell Lines.[Pubmed:28208804]
Int J Mol Sci. 2017 Feb 13;18(2). pii: ijms18020392.
Hazelnut shells, a by-product of the kernel industry processing, are reported to contain high amount of polyphenols. However, studies on the chemical composition and potential effects on human health are lacking. A methanol hazelnut shells extract was prepared and dried. Our investigation allowed the isolation and characterization of different classes of phenolic compounds, including neolignans, and a diarylheptanoid, which contribute to a high total polyphenol content (193.8 +/- 3.6 mg of gallic acid equivalents (GAE)/g of extract). Neolignans, lawsonicin and Cedrusin, a cyclic diarylheptanoid, carpinontriol B, and two phenol derivatives, C-veratroylglycol, and beta-hydroxypropiovanillone, were the main components of the extract (0.71%-2.93%, w/w). The biological assays suggested that the extract could be useful as a functional ingredient in food technology and pharmaceutical industry showing an in vitro scavenging activity against the radical 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) (EC50 = 31.7 mug/mL with respect to alpha-tocopherol EC50 = 10.1 mug/mL), and an inhibitory effect on the growth of human cancer cell lines A375, SK-Mel-28 and HeLa (IC50 = 584, 459, and 526 mug/mL, respectively). The expression of cleaved forms of caspase-3 and poly(ADP-ribose) polymerase-1 (PARP-1) suggested that the extract induced apoptosis through caspase-3 activation in both human malignant melanoma (SK-Mel-28) and human cervical cancer (HeLa) cell lines. The cytotoxic activity relies on the presence of the neolignans (balanophonin), and phenol derivatives (gallic acid), showing a pro-apoptotic effect on the tested cell lines, and the neolignan, Cedrusin, with a cytotoxic effect on A375 and HeLa cells.